Peter Jensen, DO
Ophthalmology · Rock Springs, WYNPI 1306826938
Payments from drug & device makers
What this record shows
This record is dominated by charitable contributions: $1,700 of the $2,021 with a category attached, or 84.1%. Microsurgical Technology, Inc. accounts for 84.1% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $1,734 and has fallen 97.4% since, to $45 in 2025.
Across 14 payments — averaging $144.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Microsurgical Technology, Inc.$2K
- Alcon$174
- Regeneron Healthcare Solutions, Inc.$132
- Novartis$15
What the payments were for
- Food & beverage$32116%
- Charitable contribution$1,70084%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Microsurgical Technology, Inc. | 1 | $1,700 |
| Alcon | 5 | $174 |
| Regeneron Healthcare Solutions, Inc. | 7 | $132 |
| Novartis | 1 | $15 |
How this compares
Too few ophthalmology providers in Wyomingto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 194 | $9,859 |
| Latanoprost | 259 | $2,087 |
| Difluprednate | 16 | $1,793 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 95 | $1,483 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 15 | $1,433 |
| Atropine Sulfate | 28 | $1,010 |
| Fluorometholone | 13 | $877 |
| Prednisolone Acetate | 29 | $827 |
| Brimonidine Tartrate | 43 | $493 |
| Acetazolamide ErAcetazolamide | 15 | $417 |
| Timolol Maleate | 29 | $344 |
| Diclofenac Sodium | 19 | $253 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 14 | $161 |
| Dorzolamide Hcl | 18 | $123 |
| Azithromycin | 16 | $73 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Rock Springs
- Samuel NavonGillette$2K
- Barry WelchCody$385
- Shaun ShaferLaramie$253
- Matthew DoddsCasper$149
- Bairn WalkerSheridan$88
- Patricia SteppCheyenne$79
- William StewartCheyenne$55
- Peter LarsenNewcastle$36
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.